Associated Papers
Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease.
Pogoda C et al.
Frontiers in Cardiovascular Medicine, 2023
Fabry Disease in Slovakia: How the Situation Has Changed over 20 Years of Treatment.
Jurickova K et al.
Journal of Personalized Medicine, 2022
Detailed Phenotype of GLA Variants Identified by the Nationwide Neurological Screening of Stroke Patients in the Czech Republic.
Reková P et al.
Journal of Clinical Medicine, 2021
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year.
Müntze J et al.
Clinical Pharmacology and Therapeutics, 2019
Fabry disease cardiomyopathy: A state-of-the-art review.
Pande S et al.
Progress in Cardiovascular Diseases, 0
Select a paper to view details